These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
381 related items for PubMed ID: 1317968
1. In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Culver KW, Ram Z, Wallbridge S, Ishii H, Oldfield EH, Blaese RM. Science; 1992 Jun 12; 256(5063):1550-2. PubMed ID: 1317968 [Abstract] [Full Text] [Related]
4. Gene therapy for the treatment of brain tumors using intra-tumoral transduction with the thymidine kinase gene and intravenous ganciclovir. Oldfield EH, Ram Z, Culver KW, Blaese RM, DeVroom HL, Anderson WF. Hum Gene Ther; 1993 Feb 12; 4(1):39-69. PubMed ID: 8384892 [Abstract] [Full Text] [Related]
5. The effect of thymidine kinase transduction and ganciclovir therapy on tumor vasculature and growth of 9L gliomas in rats. Ram Z, Walbridge S, Shawker T, Culver KW, Blaese RM, Oldfield EH. J Neurosurg; 1994 Aug 12; 81(2):256-60. PubMed ID: 8027810 [Abstract] [Full Text] [Related]
6. Vesicular stomatitis virus G pseudotyped retrovector mediates effective in vivo suicide gene delivery in experimental brain cancer. Galipeau J, Li H, Paquin A, Sicilia F, Karpati G, Nalbantoglu J. Cancer Res; 1999 May 15; 59(10):2384-94. PubMed ID: 10344748 [Abstract] [Full Text] [Related]
7. Toxicity studies of retroviral-mediated gene transfer for the treatment of brain tumors. Ram Z, Culver KW, Walbridge S, Frank JA, Blaese RM, Oldfield EH. J Neurosurg; 1993 Sep 15; 79(3):400-7. PubMed ID: 8395592 [Abstract] [Full Text] [Related]
8. Intravenous RMP-7 increases delivery of ganciclovir into rat brain tumors and enhances the effects of herpes simplex virus thymidine kinase gene therapy. LeMay DR, Kittaka M, Gordon EM, Gray B, Stins MF, McComb JG, Jovanovic S, Tabrizi P, Weiss MH, Bartus R, Anderson WF, Zlokovic BV. Hum Gene Ther; 1998 May 01; 9(7):989-95. PubMed ID: 9607410 [Abstract] [Full Text] [Related]
9. In vivo transfer of the human interleukin-2 gene: negative tumoricidal results in experimental brain tumors. Ram Z, Walbridge S, Heiss JD, Culver KW, Blaese RM, Oldfield EH. J Neurosurg; 1994 Mar 01; 80(3):535-40. PubMed ID: 8113867 [Abstract] [Full Text] [Related]
10. Ablation of tumor cells in vivo by direct injection of HSV-thymidine kinase retroviral vector and ganciclovir therapy. Howard BD, Kalthoff H, Fong TC. Ann N Y Acad Sci; 1999 Jun 30; 880():352-65. PubMed ID: 10415879 [Abstract] [Full Text] [Related]
13. Stereotactic injection of herpes simplex thymidine kinase vector producer cells (PA317-G1Tk1SvNa.7) and intravenous ganciclovir for the treatment of progressive or recurrent primary supratentorial pediatric malignant brain tumors. Kun LE, Gajjar A, Muhlbauer M, Heideman RL, Sanford R, Brenner M, Walter A, Langston J, Jenkins J, Facchini S. Hum Gene Ther; 1995 Sep 01; 6(9):1231-55. PubMed ID: 8527482 [Abstract] [Full Text] [Related]
16. Gene therapy of malignant brain tumors: a rat glioma line bearing the herpes simplex virus type 1-thymidine kinase gene and wild type retrovirus kills other tumor cells. Takamiya Y, Short MP, Ezzeddine ZD, Moolten FL, Breakefield XO, Martuza RL. J Neurosci Res; 1992 Nov 01; 33(3):493-503. PubMed ID: 1335091 [Abstract] [Full Text] [Related]